Skip to main content
letter
. 2020 Aug 13;93(2):615–617. doi: 10.1002/jmv.26387

Figure 1.

Figure 1

Therapeutic strategies for targeting Toll‐Like receptors (TLRs) against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). IFN, interferon; IL, interleukin; NF‐κB, nuclear factor κB